Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korean Pharmas To Highlight Lung Cancer Pipeline Progress At AACR

Executive Summary

Several South Korean companies are set to present updates on their growing lung cancer pipelines at a major meeting in Chicago this month, underlining the high unmet needs and strong R&D interest in this area by firms in the country.  
Advertisement

Related Content

Hanmi Halts Olmutinib Development After Alliances Crumble
Hanmi Mulls New Trial Strategy As ZAI Lab Ends Olmutinib Partnership
Poziotinib Shows Promise In EGFR Exon 20 Mutant NSCLC
Deal Watch: Sanofi Begins 2017 By Ending Vaccine JV, Completing Swap With Boehringer
INTERVIEW: Oscotec Lays Out Global Ambitions For RA, Cancer Drugs
Yuhan, Luoxin Deal Underscores Asian NSCLC Therapy Needs
Hanmi Inks Record Korean Deal, With Boehringer For Cancer Therapy

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100722

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel